2-Bromothiazole → 4-(1,3-Thiazol-2-yl)benzaldehyde

HRID 380203

반응식

HRID 380203 반응식
[Mg].CO[CH:4]([O:12]C)[C:5]1[CH:10]=[CH:9][C:8](Br)=[CH:7][CH:6]=1.Br[C:15]1[S:16][CH:17]=[CH:18][N:19]=1.C1C=CC(P(C2C=CC=CC=2)CCCP(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>C1COCC1.O>[S:16]1[CH:17]=[CH:18][N:19]=[C:15]1[C:8]1[CH:7]=[CH:6][C:5]([CH:4]=[O:12])=[CH:10][CH:9]=1

참가 물질

7

반응물 4

HCID 764302-BromothiazoleHCID 812191,3-Bis(diphenylphosphino)propane2회HCID 6883421-Bromo-4-(dimethoxymethyl)benzeneHCID 5462224Magnesium

생성물 1

HCID 105356554-(1,3-Thiazol-2-yl)benzaldehyde

시약·촉매·용매 2

HCID 962Water용매HCID 8028Tetrahydrofuran용매3회

반응 조건

온도
60 °C

실험 절차

Under argon, 9.2 g (379 mmol) of magnesium are placed in 84 ml of THF and heated to 60° C. A solution of 82.6 g (357 mmol) of 4-bromobenzaldehyde dimethyl acetal (for preparation see J. Org. Chem. 56, 4280 (1991)) in 677 ml of THF is added dropwise thereto within a period of 30 min and the mixture is stirred at boiling temperature for a further 40 min. The Grignard solution is cooled, decanted into a dropping funnel and added dropwise within a period of 30 min to a reddish suspension of 31.7 ml (338 mmol) of 2-bromothiazole (Fluka, Buchs, Switzerland) and 5.39 g (9.95 mmol) of DPPP in 1.68 liters of THF. The mixture is stirred at room temperature for 12 hours; a further 5.39 g of DPPP are added and the mixture is stirred for a further 7 hours. 840 ml of water are added and the mixture is stirred for 10 min; the THF is evaporated off using a rotary evaporator and the residue is stirred for 1.5 hours in 1.0 liter of ether and 340 ml of 2N HCl. The aqueous phase is separated off and extracted 2× with ethyl acetate. The organic phases are washed 2× with 0.5N HCl, water, sat. NaHCO3 solution, water and brine, dried (Na2SO4) and concentrated by evaporation. Chromatography (SiO2; hexane/ethyl acetate 4:1) and digestion in hexane yield the title compound: TLC: Rf=0.21 (hexane/ethyl acetate 3:1); m.p: 91-92° C.; Anal. (C10H7NOS) calc. C, 63.47, H, 3.73, N, 7.40, S, 16.94: found C, 63.14, H, 3.79, N, 7.27, S, 17.08; 1H-NMR (CDCl3) δ 10.05 (s, HCO), 8.15 (d, J=8, 2H), 7.95 (m, 3H), 7.45 (d, J=3,1H).

후처리

  1. customfor a further 40 min
  2. temperatureThe Grignard solution is cooled
  3. customdecanted into a dropping funnel
  4. stirringThe mixture is stirred at room temperature for 12 hours
  5. stirringthe mixture is stirred for a further 7 hours
  6. stirringthe mixture is stirred for 10 min
  7. customthe THF is evaporated off
  8. customa rotary evaporator
  9. stirringthe residue is stirred for 1.5 hours in 1.0 liter of ether
  10. customThe aqueous phase is separated off
  11. extractionextracted 2× with ethyl acetate
  12. washThe organic phases are washed 2× with 0.5N HCl, water, sat. NaHCO3 solution, water and brine
  13. dry with materialdried (Na2SO4)
  14. concentrationconcentrated by evaporation

출처 및 근거

ORD 기록
ord-4f6f96bf208941a988ef8d3bff0e663b
출처 데이터셋
uspto-grants-2001_10
특허 번호
US06300519B1

연결된 노트

불러오는 중…